Subscribe to Newsletter

Discovery & Development

Discovery & Development Dosage Forms

Three Trends to Watch in Oral Solid Dosages

| Jennifer Gattari | 4 min read

Oral solid dosage, HPAPIs, OSD development, OSD formulations, poorly soluble drugs, fixed-dose combinations, controlled release

Discovery & Development Drug Discovery

A New Computational Approach to Complex Molecule Synthesis

| Stephanie Vine | 8 min read

Early work from Scripps researchers uses a virtual library to synthesize plant-based metabolites: picrotoxanes.

Discovery & Development Drug Discovery

Breast Cancer Breakthrough

| Rob Coker

Scientists develop treatment that leads to complete regression of breast tumors in mice.

Discovery & Development Drug Discovery

Venom: The Last Advance

| Rob Coker | 2 min read

How snake venom, genomic data, and deep learning computation methods have combined to bring new advances in drug discovery.

Discovery & Development Drug Discovery

Examining the Effectiveness of Antidepressants

| Stephanie Vine | 2 min read

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

Discovery & Development Clinical Trials

AI in Oncology: The Bridge Between the Patient and the Practice

| 2 min read

Using AI to improve oncology care and find the right clinical trials for patients.

Discovery & Development Clinical Trials

Asking the Right Questions in R&D

| 3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Discovery & Development Drug Discovery

The Trick With Senolytics

| 4 min read

How understanding and manipulating senescence dynamics could optimize cancer therapies and improve patient outcomes.

Discovery & Development Advanced Medicine

Complex DNA; No Compromises

| Daniel Lin-Arlow | 4 min read

How can you ensure your gene therapy research won’t be slowed down by synthesis problems?

Discovery & Development Advanced Medicine

Incredible Advancements

| 5 min read

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker